SLC7A11 and hepatocellular carcinoma: Sorafenib has been repeatedly reported to induce ferroptosis through the inhibition of system Xc–, contradicting the claim from the latter study that sorafenib does not trigger ferroptosis through the inhibition of system Xc− due to low SLC7A11 expression in human hepatoma cell lines.